FAAH and Alzheimer disease: The activity of FAAH was also reduced in the frontal cortices of AD patients [132], together with depleted levels of anandamide and its precursor 1-stearoyl, 2-docosahexaenoyl-sn-glycero-phosphoethanolamine-N-arachidonoyl in the midfrontal and temporal cortices of AD.